Valor202020212022202320242025TTMDespesas comerciais, gerais e administrativas1.73 B1.95 B2 B2.02 B2.23 B2.22 B2.22 BPesquisa e desenvolvimento———————Lucro operacional2.45 B3.26 B1.77 B725.6 M1.09 B1.38 B1.44 BLucro não operacional, total-226.3 M52.6 M-16.5 M44.1 M82.3 M-40 M-46.4 MDespesa com juros, líquida de juros capitalizados207.4 M212.1 M180.3 M199.6 M208.3 M224.1 M223.2 MReceitas não operacionais, líquidas das despesas com juros-401.6 M-202 M-171.5 M-171 M-186.2 M-209.1 M-202.5 MReceitas/despesas incomuns-32.1 M42.5 M-25.3 M15.5 M60.2 M-55 M-67.1 MLucro antes dos impostos2.22 B3.15 B1.59 B567.5 M958.1 M1.09 B9.82 BParticipação no lucro2.9 M26.5 M5.4 M-1.4 M-1.4 M-13.3 M-18.1 MImpostos662.1 M747.1 M302 M188.5 M212.4 M229.8 M209.3 MParticipação de minoritários900 K2.2 M1.5 M1.2 M1.1 M1.2 M1.2 MOutras receitas/despesas após impostos———————Lucro líquido antes das operações descontinuadas1.56 B2.38 B1.28 B379.2 M746 M876.5 M941.5 MOperações descontinuadas———38.8 M00—Lucro líquido1.56 B2.38 B1.28 B418 M746 M876.5 M941.5 MAjuste de diluição———————Dividendos de ações preferenciais———————Lucro líquido diluído disponível aos acionistas1.56 B2.38 B1.28 B418 M746 M876.5 M941.5 MLucro básico por ação13.7421.1312.074.88.8910.5411.37Lucro diluído por ação13.6420.95124.778.8410.4611.29Número médio de ações básicas113.26 M112.56 M106.04 M87.1 M83.9 M83.2 M—Ações diluídas114.07 M113.49 M106.62 M87.6 M84.4 M83.8 M—EBITDA3.02 B3.97 B2.35 B1.28 B1.71 B2.14 B2.05 BEBIT2.37 B3.21 B1.72 B705.6 M1.07 B1.46 B1.36 BCusto da receita9.03 B10.5 B10.49 B8.8 B9.38 B9.94 B10.07 BOutros componentes do custo———————Amortização e depreciação (fluxo de caixa)624.7 M745.1 M633.9 M577.3 M643.5 M681.1 M687.6 M
Labcorp Holdings Inc. Common Stock
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program.